Tag: Merck
India’s rise to global vaccine triumph: A journey of excellence &...
India's rich history with vaccines is a testament to the country's commitment to global health
Merck India organizes its first-ever student engagement programme in Bengaluru
Merck’s IT Centre engaged with students to understand their expectations from their future workforce
Merck delivers profitable growth at 12.9% despite challenges during FY 2022
Sales growth was driven by all regions and business sectors, particularly life science
“We expect a sea change in Indian biotech landscape”
Exclusive interaction with Aditya Sharma, Head-Bioprocessing Business, Merck Life Science India
Merck to acquire Imago BioSciences for US$1.35 billion
Imago is a clinical stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases
Merck appoints Robert M. Davis as its new Chairman
Davis, who currently serves as President and Chief Executive Officer, became Merck’s President in April 2021
Merck India sparks curiosity in students during visit to its high-tech...
The Merck M Lab™ Collaboration Center tour for school children focuses on sparking curiosity in the next generation of scientists
BioVoice eMagazine October 2022 Issue 1 Volume 3
Click to Read: BioVoice News October 2022 Issue 1 Volume 3
To refresh the journey of Indian vaccines, the current edition of the magazine dives deeper...
Merck India’s 3rd Annual Pharma Forum 2022 to be held in...
The event scheduled on 10th August is focused on shaping the next gen processing of pharma manufacturing
Pratima Reddy is the new Managing Director of Merck Specialities
Pratima will lead India's healthcare strategy and operations, effective August 1, 2022, as successor to Anandram Narasimhan, transitioning into a regional role at APAC